Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications
暂无分享,去创建一个
[1] A. Beekman,et al. The Association Between Metabolic Syndrome, Obesity-Related Outcomes, and ADHD in Adults With Comorbid Affective Disorders , 2018, Journal of attention disorders.
[2] M. Torrens,et al. Metabolic Syndrome among Individuals with Heroin use Disorders on Methadone Therapy: Prevalence, Characteristics, and Related Factors , 2018, Substance abuse.
[3] A. I. Nash. Crosstalk between insulin and dopamine signaling: A basis for the metabolic effects of antipsychotic drugs , 2017, Journal of Chemical Neuroanatomy.
[4] F. Kapczinski,et al. Metabolic syndrome in subjects with bipolar disorder and major depressive disorder in a current depressive episode: Population-based study: Metabolic syndrome in current depressive episode. , 2017, Journal of psychiatric research.
[5] B. Miller. Impaired Glucose Homeostasis in First-Episode Schizophrenia , 2017 .
[6] Q. Foguet-Boreu,et al. Anxiety disorders and risk of stroke: A systematic review and meta-analysis , 2017, European Psychiatry.
[7] Fang Tang,et al. Association between anxiety and metabolic syndrome: A systematic review and meta-analysis of epidemiological studies , 2017, Psychoneuroendocrinology.
[8] B. Penninx. Depression and cardiovascular disease: Epidemiological evidence on their linking mechanisms , 2017, Neuroscience & Biobehavioral Reviews.
[9] O. Howes,et al. Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysis , 2017, JAMA psychiatry.
[10] A. Amare,et al. The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies , 2017, Translational Psychiatry.
[11] R. O. Oude Voshaar,et al. Metabolic dysregulation and late-life depression: a prospective study , 2016, Psychological Medicine.
[12] Gregory H Gorman,et al. Autism Spectrum Disorders and Metabolic Complications of Obesity. , 2016, The Journal of pediatrics.
[13] M. Dayabandara,et al. Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis , 2016, BMC Psychiatry.
[14] I. Nordhus,et al. Exercise as a treatment for depression: A meta-analysis. , 2016, Journal of affective disorders.
[15] D. Mohr,et al. Major depressive disorder , 2016, Nature Reviews Disease Primers.
[16] D. Vancampfort,et al. The Prevalence of Metabolic Syndrome in Alcohol Use Disorders: A Systematic Review and Meta-analysis. , 2016, Alcohol and alcoholism.
[17] S. Ayis,et al. Cardiovascular risk factors among patients with schizophrenia, bipolar, depressive, anxiety, and personality disorders , 2016, European Psychiatry.
[18] B. Penninx,et al. BIDIRECTIONAL PROSPECTIVE ASSOCIATIONS OF METABOLIC SYNDROME COMPONENTS WITH DEPRESSION, ANXIETY, AND ANTIDEPRESSANT USE , 2016, Depression and anxiety.
[19] J Licinio,et al. From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways , 2016, Molecular Psychiatry.
[20] A. Dehghan,et al. Polygenic dissection of major depression clinical heterogeneity , 2016, Molecular Psychiatry.
[21] B. Penninx,et al. Anxiety and new onset of cardiovascular disease: critical review and meta-analysis , 2016, British Journal of Psychiatry.
[22] B. Baune,et al. Anti‐inflammatory agents in the treatment of bipolar depression: a systematic review and meta‐analysis , 2016, Bipolar disorders.
[23] A. Yung,et al. Cardiometabolic risk factors in young people at ultra-high risk for psychosis: A systematic review and meta-analysis , 2016, Schizophrenia Research.
[24] R. Emsley,et al. A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia , 2016, Schizophrenia Research.
[25] S. Kennedy,et al. Inflammatory Cytokines and Antipsychotic-Induced Weight Gain: Review and Clinical Implications , 2016, Molecular Neuropsychiatry.
[26] L. Rojo,et al. Metabolic syndrome and obesity among users of second generation antipsychotics: A global challenge for modern psychopharmacology. , 2015, Pharmacological research.
[27] D. Vancampfort,et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis , 2015, World psychiatry : official journal of the World Psychiatric Association.
[28] M. Emul,et al. Etiology of cardiovascular disease in patients with schizophrenia: current perspectives , 2015, Neuropsychiatric disease and treatment.
[29] Celso Arango,et al. Inflammation in schizophrenia: A question of balance , 2015, Neuroscience & Biobehavioral Reviews.
[30] Z. Steel,et al. The prevalence and risk of metabolic syndrome and its components among people with posttraumatic stress disorder: a systematic review and meta-analysis. , 2015, Metabolism: clinical and experimental.
[31] G. Carrà,et al. Schizoaffective disorder and metabolic syndrome: A meta-analytic comparison with schizophrenia and other non-affective psychoses. , 2015, Journal of psychiatric research.
[32] V. Sari-Sarraf,et al. A combined continuous and interval aerobic training improves metabolic syndrome risk factors in men , 2015, International journal of general medicine.
[33] D. Henderson,et al. Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses. , 2015, The lancet. Psychiatry.
[34] B. Penninx,et al. Metabolic syndrome in patients with bipolar disorder: comparison with major depressive disorder and non-psychiatric controls. , 2015, Journal of psychosomatic research.
[35] O. Mors,et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. , 2014, JAMA psychiatry.
[36] A. Tentler,et al. Managing cardiovascular disease risk in patients treated with antipsychotics: a multidisciplinary approach , 2014, Journal of multidisciplinary healthcare.
[37] S. Faraone,et al. Attention-Deficit/Hyperactivity Disorder and Adverse Health Outcomes in Adults , 2014, The Journal of nervous and mental disease.
[38] M. Preisig,et al. Depression with atypical features and increase in obesity, body mass index, waist circumference, and fat mass: a prospective, population-based study. , 2014, JAMA psychiatry.
[39] K. Scott,et al. Depression, anxiety and incident cardiometabolic diseases , 2014, Current opinion in psychiatry.
[40] Seena Fazel,et al. Risks of all‐cause and suicide mortality in mental disorders: a meta‐review , 2014, World psychiatry : official journal of the World Psychiatric Association.
[41] Robert A Schoevers,et al. Inflammatory and Metabolic Dysregulation and the 2-Year Course of Depressive Disorders in Antidepressant Users , 2014, Neuropsychopharmacology.
[42] A. Tiedemann,et al. Physical activity interventions for people with mental illness: a systematic review and meta-analysis. , 2014, The Journal of clinical psychiatry.
[43] P. Mortensen,et al. Excess early mortality in schizophrenia. , 2014, Annual review of clinical psychology.
[44] A. Bunevičius,et al. Depression but not anxiety is associated with metabolic syndrome in primary care based community sample , 2014, Psychoneuroendocrinology.
[45] D. Vancampfort,et al. A meta‐analysis of cardio‐metabolic abnormalities in drug naïve, first‐episode and multi‐episode patients with schizophrenia versus general population controls , 2013, World psychiatry : official journal of the World Psychiatric Association.
[46] Peter D. Drummond,et al. Obesity and psychiatric disorders: Commonalities in dysregulated biological pathways and their implications for treatment , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[47] Femke Lamers,et al. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile , 2013, BMC Medicine.
[48] S. Moebus,et al. Prevalence of the metabolic syndrome in patients with borderline personality disorder: results from a cross-sectional study , 2013, European Archives of Psychiatry and Clinical Neuroscience.
[49] D. Vancampfort,et al. Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis. , 2013, Schizophrenia bulletin.
[50] P. Sienaert,et al. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. , 2013, The American journal of psychiatry.
[51] U. Albert,et al. Metabolic syndrome and obsessive-compulsive disorder: a naturalistic Italian study. , 2013, General hospital psychiatry.
[52] A. Mitchell,et al. Differences in the prescribing of medication for physical disorders in individuals with v. without mental illness: meta-analysis , 2012, British Journal of Psychiatry.
[53] T. Postolache,et al. Neuroinflammation and depression: the role of indoleamine 2,3-dioxygenase (IDO) as a molecular pathway. , 2012, Psychosomatic Medicine.
[54] W. Honer,et al. Cardiovascular side-effects of antipsychotic drugs: the role of the autonomic nervous system. , 2012, Pharmacology & therapeutics.
[55] K. Merikangas,et al. Structure of major depressive disorder in adolescents and adults in the US general population , 2012, British Journal of Psychiatry.
[56] An Pan,et al. Bidirectional Association Between Depression and Metabolic Syndrome , 2012, Diabetes Care.
[57] Sarah Stockton,et al. Lithium toxicity profile: a systematic review and meta-analysis , 2012, The Lancet.
[58] D. Vancampfort,et al. Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices , 2011, Psychological Medicine.
[59] M. Bloch,et al. The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis , 2011, Neuropsychopharmacology.
[60] S. Bandinelli,et al. Metabolic depression: a chronic depressive subtype? Findings from the InCHIANTI study of older persons. , 2011, The Journal of clinical psychiatry.
[61] J Licinio,et al. The procognitive effects of leptin in the brain and their clinical implications , 2010, International journal of clinical practice.
[62] S. Bartels,et al. A Pilot Evaluation of the In SHAPE Individualized Health Promotion Intervention for Adults with Mental Illness , 2010, Community Mental Health Journal.
[63] B. Penninx,et al. Longitudinal Evidence for Unfavorable Effects of Antidepressants on Heart Rate Variability , 2010, Biological Psychiatry.
[64] A. Serretti,et al. Antidepressants and body weight: a comprehensive review and meta-analysis. , 2010, The Journal of clinical psychiatry.
[65] Lawrence Joseph,et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. , 2010, Journal of the American College of Cardiology.
[66] R. Shelton,et al. Eating ourselves to death (and despair): The contribution of adiposity and inflammation to depression , 2010, Progress in Neurobiology.
[67] J. Calabrese,et al. Metabolic syndrome in patients enrolled in a clinical trial of aripiprazole in the maintenance treatment of bipolar I disorder: a post hoc analysis of a randomized, double-blind, placebo-controlled trial. , 2010, The Journal of clinical psychiatry.
[68] A. AlShehri. Metabolic syndrome and cardiovascular risk. , 2010, Journal of family & community medicine.
[69] M. DelBello,et al. Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials. , 2010, Bipolar disorders.
[70] F. Zitman,et al. Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use , 2009, Acta psychiatrica Scandinavica.
[71] F. Zitman,et al. Depression Is Associated With Decreased Blood Pressure, but Antidepressant Use Increases the Risk for Hypertension , 2009, Hypertension.
[72] Philippe Moulin,et al. Associations Between Anxiety, Depression, and the Metabolic Syndrome , 2007, Biological Psychiatry.
[73] J. Calabrese,et al. Metabolic Syndrome in Patients Enrolled in a Clinical Trial of Aripiprazole in the Maintenance Treatment of Bipolar Disorder , 2007 .
[74] S. Kennedy,et al. Medical comorbidity in bipolar disorder: reprioritizing unmet needs , 2007, Current opinion in psychiatry.
[75] S. Blair,et al. Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial. , 2007, JAMA.
[76] J. Newcomer. Antipsychotic medications: metabolic and cardiovascular risk. , 2007, The Journal of clinical psychiatry.
[77] P. Turnbaugh,et al. Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.
[78] A. Uitterlinden,et al. A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. , 2002, Diabetes.
[79] O. Mors,et al. Effect of Anti-inflammatory Treatment on Depression , Depressive Symptoms , and Adverse Effects , 2014 .
[80] P. Burman,et al. Assessment of Insulin Resistance and Metabolic Syndrome in Drug Naive Patients of Bipolar Disorder , 2012, Indian Journal of Clinical Biochemistry.
[81] H. Minuk,et al. Metabolic syndrome. , 2005, Journal of insurance medicine.